Brooke Alhanti
Overview
Explore the profile of Brooke Alhanti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
426
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rousseau J, Weber J, Alhanti B, Saver J, Messe S, Schwamm L, et al.
JAMA Netw Open
. 2025 Mar;
8(3):e250548.
PMID: 40072434
Importance: Tenecteplase is an alternative to alteplase for emergency treatment of acute ischemic stroke. However, limited data are available comparing their clinical effectiveness in routine clinical practice. Objective: To compare...
2.
Jacobs J, Ayodele I, Bress A, Sterling M, Pandey A, Derington C, et al.
Circ Heart Fail
. 2024 Nov;
18(1):e012357.
PMID: 39527624
Background: Fewer than 20% of eligible patients with heart failure with reduced ejection fraction receive all 4 pillars of guideline-directed medical therapy. Understanding disparities by race, ethnicity, sex, and adverse...
3.
Mac Grory B, Sun J, Alhanti B, Lusk J, Li F, Adeoye O, et al.
JAMA Neurol
. 2024 Oct;
81(12):1250-1262.
PMID: 39466286
Importance: Clinical trials have suggested that prehospital management in a mobile stroke unit (MSU) improves functional outcomes in patients with acute ischemic stroke who are potentially eligible for intravenous thrombolysis,...
4.
Royan R, Ayodele I, Stamm B, Alhanti B, Sheth K, Pruitt P, et al.
Ann Emerg Med
. 2024 Oct;
85(2):132-143.
PMID: 39453306
Study Objective: Interhospital transfer is often required in the care of patients with hemorrhagic stroke. Guidelines recommend a door-in-door-out (DIDO) time of ≤120 minutes at the transferring emergency department (ED);...
5.
Rymer J, Pichan C, Page C, Alhanti B, Bhatt D, Kochar A, et al.
J Card Fail
. 2024 Oct;
30(10):1233-1240.
PMID: 39389732
Introduction: Little is known about the use of cangrelor in patients with myocardial infarction (MI) presenting with cardiogenic shock (CS). Methods: CAMEO (Cangrelor in Acute MI: Effectiveness and Outcomes) is...
6.
Watson C, Alhanti B, Zhao C, Havrilesky L, Davidson B
JCO Oncol Pract
. 2024 Sep;
:OP2300571.
PMID: 39303173
Purpose: Unanticipated health care resource utilization, in the form of either emergency department utilization (EDU) or hospital admission (HA), may be an indicator of lower-quality cancer care. The objective of...
7.
Sandhu A, Grau-Sepulveda M, Witting C, Tisdale R, Zheng J, Rodriguez F, et al.
Circ Heart Fail
. 2024 Sep;
17(10):e011177.
PMID: 39291393
Background: Disparities in guideline-based quality measures likely contribute to differences in heart failure (HF) outcomes. We evaluated between- and within-hospital differences in the quality of care across sex, race, ethnicity,...
8.
Rymer J, Alhanti B, Kemp S, Bhatt D, Kochar A, Angiolillo D, et al.
J Soc Cardiovasc Angiogr Interv
. 2024 Aug;
3(2):101202.
PMID: 39132213
Background: Little is known about the bleeding risk associated with cangrelor use in patients with myocardial infarction (MI) who are exposed to an oral P2Y inhibitor before coronary angiography. Methods:...
9.
Hughes F, Parsons L, Levy J, Shindell D, Alhanti B, Ohnuma T, et al.
Anesthesiology
. 2024 Aug;
141(4):779-789.
PMID: 39105660
No abstract available.
10.
Sullivan 2nd L, Maul A, Young R, Boursiquot B, Khedagi A, Alhanti B, et al.
Heart Rhythm
. 2024 Jul;
22(3):627-628.
PMID: 39029883
No abstract available.